Table 3 Clinical characteristics between PARP1 low and high expression groups
Characteristic | Total (n = 72) | PARP1 expression | PARP1 expression | P-value |
|---|---|---|---|---|
Low | High | |||
Age (year) | Â | Â | Â | 0.238 |
 < 55 | 36 (50.0) | 21 (29.2) | 15 (20.8) |  |
 ≥ 55 | 36 (50.0) | 15 (20.8) | 21 (29.2) |  |
FIGO stage (2014) | Â | Â | Â | 0.710 |
 I and II | 8 (11.1) | 3 (4.2) | 5 (6.9) |  |
 III and IV | 64 (88.9) | 33 (45.8) | 31 (43.1) |  |
Diameter (cm) | Â | Â | Â | 0.813 |
 < 8 | 40 (55.6) | 19 (26.4) | 21 (29.2) |  |
 ≥ 8 | 32 (44.4) | 17 (23.6) | 15 (20.8) |  |
Ascitic fluid | Â | Â | Â | 0.312 |
 Yes | 23 (31.9) | 9 (12.5) | 14 (19.4) |  |
 NO | 49 (68.1) | 27 (37.5) | 22 (30.6) |  |
CA125 (U/ml) | Â | Â | Â | 0.115 |
 < 35 | 4 (5.6) | 0 (0.0) | 4 (5.6) |  |
 ≥ 35 | 68 (94.4) | 36 (50.0) | 32 (44.4) |  |
PD-L1 expression | Â | Â | Â | 0.341 |
 Low | 41 (56.9) | 23 (31.9) | 18 (25.0) |  |
 High | 31 (43.1) | 13 (18.1) | 18 (25.0) |  |
CD8 expression (cancer tissue) | Â | Â | 0.240 | |
 Low | 38 (52.8) | 17 (23.6) | 21 (29.2) |  |
 High | 34 (47.2) | 19 (26.4) | 15 (20.8) |  |